Budget 2026: FM Sitharaman Unveils Rs 10,000 Cr 'BioPharma Shakti' for Global Hub

• FM Nirmala Sitharaman announced 'BioPharma Shakti' with Rs 10,000 crore outlay over five years in Budget 2026.
• The initiative aims to make India a global biopharma manufacturing hub by supporting domestic production of biologics and biosimilars.
• Sitharaman also proposed the BioPharma Strategy for Health Advancement to strengthen India’s digital healthcare ecosystem.
• The budget includes measures to rejuvenate 200 legacy industrial clusters and promote India as a sports goods manufacturing hub.
• India aims for long-term development and a 'Vikasit Bharat' despite global uncertainties and supply chain disruptions.

Why It Matters: Budget 2026 introduces 'BioPharma Shakti' with Rs 10,000 crore to establish India as a global biopharma hub.